ISOGlyP statistics

info info

Citations per year

Number of citations per year for the bioinformatics software tool ISOGlyP
info

Tool usage distribution map

This map represents all the scientific publications referring to ISOGlyP per scientific context
info info

Associated diseases

info

Popular tool citations

chevron_left Glycosylation site prediction chevron_right
Want to access the full stats & trends on this tool?

ISOGlyP specifications

Information


Unique identifier OMICS_19841
Name ISOGlyP
Alternative names Isoform Specific O-Glycosylation Prediction, OGPET (O-Glycosylation Prediction Electronic Tool)
Interface Web user interface
Restrictions to use None
Input data A single or multiple sequences.
Input format FASTA
Computer skills Basic
Stability Stable
Maintained Yes

Maintainer


  • person_outline ISOGlyP team

ISOGlyP citation

library_books

Association of CTH variant with sinusoidal obstruction syndrome in children receiving intravenous busulfan and cyclophosphamide before hematopoietic stem cell transplantation

2016
Pharmacogenomics J
PMCID: 5817388
PMID: 27779248
DOI: 10.1038/tpj.2016.65

[…] ttranslational modification sites, namely, O-GalNAc (mucin type) glycosylation and serine-dependent phosphorylation. Further exploration of these two posttranslational modifications using GlycoEP and IsoGlyp revealed no evidence for differences in the glycocylation sites. On the other hand, for phosphorylation using DisPhos it is suggested that Ser403 can be phosphorylated and this is lost with Il […]


Want to access the full list of citations?
ISOGlyP funding source(s)
Supported in part by NIH Grants #5G12RR008124 from the National Center for Research Resources (NCRR)/NIH, 1R01AI070655, NCI-CA78834, and NSF-DUE0926721.

ISOGlyP review

star_border star_border star_border star_border star_border
star star star star star

Warren Wakarchuk

star_border star_border star_border star_border star_border
star star star star star
Web
IsoGlyP is a very useful tool for the prediction of O-glycan sequons. We have been using it to design sites of O-Glycosylation on human proteins which are tailored to specific ppGalNAcT enzymes, and it works well. Our first publication using this approach is being submitted soon.